Skip to content

Efficacy of Dhanwantara taila 101 avartita capsules intervention in Dyspareunia

Add on effect of Dhanwantara Taila 101 Avartita Capsules in Paripluta Yonivyapat w.s.r to Dyspareunia - A Randomized Comparative Clinical Trial - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067163
Enrollment
20
Registered
2024-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N941- Dyspareunia

Interventions

None listed

Sponsors

Dr Pratibha Walikar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women of sexually active age group between 20-50 years of age. 2.Subjects complaining of pain during or after sexual intercourse. 3.Subjects having pain in 80 percent of sexual encounters with sexual frequency of at least 2/week.

Exclusion criteria

Exclusion criteria: 1.Past sexual assault history 2.Imperforate hymen 3.Anatomical narrow introitus or vaginal shortening 4.Pregnancy and Lactation 5.Known cases of Endometriosis, STD, Benign & Malignant conditions, IBS, Cystitis, Pelvic adhesions, Multiple sclerosis, Fibroids, uncontrolled DM and HTN. 6.Subjects who are on medications like birth control hormonal pills & Anti-depressant drugs. 7.Subjects with fixed retroverted uterus. 8.Vaginismus.

Design outcomes

Primary

MeasureTime frame
The Primary outcome will be Dhanwantara taila 101 Avartita capsules may help in relieving the symptoms of Dyspareunia.Timepoint: Subjective parameters will be assessed on 0th day,8th day,15th day,30th day and 60th day.

Secondary

MeasureTime frame
To improve the quality of life in dyspareuniaTimepoint: Subjective parameters will be assessed on 0th day,8th day,15th day,30th day and 60th day.

Countries

India

Contacts

Public ContactDr Kashavva Hiremath

KAHERS Shri B.M.Kankanwadi Ayurveda Mahavidyalaya college And Research centre

drkvhiremath@gmail.com9448945687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026